129 related articles for article (PubMed ID: 25748092)
1. Catechol-O-methyltransferase genotype and response to Compensatory Cognitive Training in outpatients with schizophrenia.
Burton CZ; Vella L; Kelsoe JR; Bilder RM; Twamley EW
Psychiatr Genet; 2015 Jun; 25(3):131-4. PubMed ID: 25748092
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
[TBL] [Abstract][Full Text] [Related]
3. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
[TBL] [Abstract][Full Text] [Related]
4. Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia.
Twamley EW; Hua JP; Burton CZ; Vella L; Chinh K; Bilder RM; Kelsoe JR
Schizophr Res; 2014 Oct; 159(1):114-7. PubMed ID: 25139113
[TBL] [Abstract][Full Text] [Related]
5. Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
Lopez-Garcia P; Young Espinoza L; Molero Santos P; Marin J; Ortuño Sanchez-Pedreño F
Psychiatry Res; 2013 Jul; 208(2):118-24. PubMed ID: 23102922
[TBL] [Abstract][Full Text] [Related]
6. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
Neuhaus AH; Opgen-Rhein C; Urbanek C; Hahn E; Ta TM; Seidelsohn M; Strathmann S; Kley F; Wieseke N; Sander T; Dettling M
Pharmacopsychiatry; 2009 Jul; 42(4):141-4. PubMed ID: 19585392
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
[TBL] [Abstract][Full Text] [Related]
9. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
[TBL] [Abstract][Full Text] [Related]
10. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
Lewandowski KE
Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
[TBL] [Abstract][Full Text] [Related]
11. No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.
Greenwood K; Hung CF; Tropeano M; McGuffin P; Wykes T
Neurosci Lett; 2011 Jun; 496(2):65-9. PubMed ID: 21458532
[TBL] [Abstract][Full Text] [Related]
12. The COMT Val158Met polymorphism moderates the association between cognitive functions and white matter microstructure in schizophrenia.
Poletti S; Mazza E; Bollettini I; Falini A; Smeraldi E; Cavallaro R; Benedetti F
Psychiatr Genet; 2016 Oct; 26(5):193-202. PubMed ID: 26999687
[TBL] [Abstract][Full Text] [Related]
13. Genetic correlate of cognitive training response in schizophrenia.
Panizzutti R; Hamilton SP; Vinogradov S
Neuropharmacology; 2013 Jan; 64(1):264-7. PubMed ID: 22992330
[TBL] [Abstract][Full Text] [Related]
14. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
Tsai SJ; Hong CJ; Liao DL; Lai IC; Liou YJ
Neuropsychobiology; 2004; 49(4):196-200. PubMed ID: 15118357
[TBL] [Abstract][Full Text] [Related]
15. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
[TBL] [Abstract][Full Text] [Related]
16. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.
Galderisi S; Maj M; Kirkpatrick B; Piccardi P; Mucci A; Invernizzi G; Rossi A; Pini S; Vita A; Cassano P; Stratta P; Severino G; Del Zompo M
Neuropsychobiology; 2005; 52(2):83-9. PubMed ID: 16037677
[TBL] [Abstract][Full Text] [Related]
18. Temperament and character in remitted and symptomatic patients with schizophrenia: modulation by the COMT Val158Met genotype.
Hori H; Fujii T; Yamamoto N; Teraishi T; Ota M; Matsuo J; Kinoshita Y; Ishida I; Hattori K; Okazaki M; Arima K; Kunugi H
J Psychiatr Res; 2014 Sep; 56():82-9. PubMed ID: 24888672
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment.
Bosia M; Zanoletti A; Spangaro M; Buonocore M; Bechi M; Cocchi F; Pirovano A; Lorenzi C; Bramanti P; Smeraldi E; Cavallaro R
Psychiatry Res; 2014 Jun; 217(1-2):9-14. PubMed ID: 24656901
[TBL] [Abstract][Full Text] [Related]
20. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
